Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

LungLife AI Inc

9H4
Current price
0.093 EUR +0.000000000046 EUR (+0.00%)
Last closed 8.5 GBX
ISIN USU5500L1045
Sector Healthcare
Industry Diagnostics & Research
Exchange Frankfurt Exchange
Capitalization 3 155 142 GBX
Yield for 12 month -90.00 %
1Y
3Y
5Y
10Y
15Y
9H4
21.11.2021 - 28.11.2021

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California. Address: 2545 West Hillcrest Drive, Thousand Oaks, CA, United States, 91320

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

175.69 GBX

P/E ratio

Dividend Yield

Current Year

+3 560 234 GBX

Last Year

+1 857 514 GBX

Current Quarter

+232 189 GBX

Last Quarter

+232 189 GBX

Current Year

+3 560 234 GBX

Last Year

+1 857 514 GBX

Current Quarter

+232 189 GBX

Last Quarter

+232 189 GBX

Key Figures 9H4

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 379 553 GBX
Operating Margin TTM -31666.67 %
PE Ratio
Return On Assets TTM -27.28 %
PEG Ratio
Return On Equity TTM -48.59 %
Wall Street Target Price 175.69 GBX
Revenue TTM 29 117 GBX
Book Value 0.28 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -73.9 %
Dividend Yield
Gross Profit TTM 24 097 GBX
Earnings per share -0.12 GBX
Diluted Eps TTM -0.12 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 9H4

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 9H4

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 9H4

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 50.6762
Price Sales TTM 108.3622
Enterprise Value EBITDA -1.8632
Price Book MRQ 0.4888

Financials 9H4

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 9H4

For 52 weeks

9.04 GBX 96.39 GBX
50 Day MA 11.92 GBX
Shares Short Prior Month
200 Day MA 23.24 GBX
Short Ratio
Shares Short
Short Percent